Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-12

Clinical Trial Update: Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation

View source ↗

Summary

This clinical trial update describes an investigation into the risk of major adverse cardiovascular events with naldemedine and other opioid-induced constipatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naldemedine (naldemedine)

Snippet

Sponsor: BioDelivery Sciences International | Conditions: Opioid-induced Constipation | Status: RECRUITING